[1] Claverie J M. Fewer genes, more noncoding RNA [J].Science, 2005, 309(5740):1529-1530.
[2] Clark M B, Mattick J S. Long noncoding RNAs in cell biology [J]. Seminars in Cell & Developmental Biology, 2011, 22(4):366-376.
[3] Mercer T R, Dinger M E, Mattick J S. Long noncoding RNAs: Insights into functions [J]. Nature Reviews Genetics, 2009, 10(3):155-159.
[4] Pasmant E, Sabbagh A, Vidaud M, et al. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS [J]. The FASEB Journal, 2011, 25(2):444-448.
[5] Congrains A, Kamide K, Oguro R, et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B [J]. Atherosclerosis, 2012, 220(2):449-455.
[6] Zhang Q, Chen C Y, Yedavalli V S R K, et al. NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV1 posttranscriptional expression [J]. mBio, 2013, 4(1):e00596.
[7] Johnson R. Long noncoding RNAs in Huntington’s disease neurodegeneration [J]. Neurobiology of Disease, 2012, 46(2):245-254.
[8] Ji P, Diederichs S, Wang W B, et al. MALAT1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in earlystage nonsmall cell lung cancer [J]. Oncogene, 2003, 22(39):8031-8041.
[9] BarsyteLovejoy D, Lau S K, Boutros P C, et al. The cmyc oncogene directly induces the H19 noncoding RNA by allelespecific binding to potentiate tumorigenesis [J]. Cancer Research, 2006, 66(10):5330-5337.
[10] 〖ZK(#〗de Kok J B, Verhaegh G W, Roelofs R W, et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors [J]. Cancer Research, 2002, 62(9):2695-2698.